| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.20▼ | 12.22▼ | 12.24▼ | 11.60▲ | 11.27▲ |
| MA10 | 12.23▼ | 12.23▼ | 12.10▲ | 11.38▲ | 9.88▲ |
| MA20 | 12.20▼ | 12.11▲ | 12.02▲ | 11.66▲ | 8.48▲ |
| MA50 | 12.17▼ | 11.67▲ | 11.61▲ | 9.87▲ | 9.15▲ |
| MA100 | 11.81▲ | 11.70▲ | 11.75▲ | 8.36▲ | 13.24▼ |
| MA200 | 11.75▲ | 11.12▲ | 10.21▲ | 9.22▲ | 86.78▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.012▼ | -0.018▼ | 0.008▲ | -0.044▼ | 0.580▲ |
| RSI | 45.029▼ | 52.694▲ | 54.945▲ | 62.304▲ | 63.766▲ |
| STOCH | 31.884 | 52.099 | 73.813 | 56.070 | 73.386 |
| WILL %R | -100.000▼ | -49.606 | -45.324 | -22.067▲ | -16.548▲ |
| CCI | -78.156 | 17.521 | 49.580 | 107.758▲ | 116.304▲ |
| ▲ PSAR&MOM | $ATRA PSAR Switch Up + Momentum | Set Alert |
|
Thursday, August 14, 2025 03:31 AM
Second Quarter 2025 Results Key Financial Results Revenue: US$17.6m (down ...
|
|
Monday, August 11, 2025 01:18 PM
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...
|
|
Tuesday, August 05, 2025 05:17 AM
We feel now is a pretty good time to analyse Atara Biotherapeutics, Inc.'s ( NASDAQ:ATRA ) business as it appears ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 11.72 | 12.49 | 11.52 | 12.29 | 149,567 |
| 14/08/25 | 12.00 | 12.11 | 11.535 | 11.72 | 41,382 |
| 13/08/25 | 11.67 | 12.2499 | 11.62 | 12.13 | 58,084 |
| 12/08/25 | 11.01 | 12.307 | 10.87 | 11.54 | 57,549 |
| 11/08/25 | 10.86 | 11.4453 | 10.32 | 10.32 | 41,861 |
| 08/08/25 | 11.03 | 11.6599 | 10.39 | 10.955 | 25,046 |
| 07/08/25 | 11.39 | 11.79 | 10.53 | 10.96 | 23,422 |
| 06/08/25 | 11.31 | 11.749 | 10.8583 | 11.385 | 24,655 |
| 05/08/25 | 11.7506 | 11.8427 | 11.1531 | 11.22 | 19,897 |
| 04/08/25 | 11.43 | 11.60 | 11.20 | 11.32 | 14,048 |
|
|
||||
|
|
||||
|
|